Podcast Summary: In Good Company with Nicolai Tangen
Episode: HIGHLIGHTS: Mala Gaonkar – Founder of SurgoCap Partners
Date: January 23, 2026
Host: Nicolai Tangen (CEO, Norges Bank Investment Management)
Guest: Mala Gaonkar (Founder, SurgoCap Partners; Former Founding Partner, Lone Pine Capital)
Overview
In this highlights episode, Nicolai Tangen engages in a candid conversation with Mala Gaonkar, celebrated founder of SurgoCap Partners. Gaonkar reflects on her investment philosophy, the evolution of technology within industries, her approach to risk and concentration, the challenges and thrill of shorting stocks, and her role as a pioneering woman in finance. The discussion is rich with insights on identifying great companies, leveraging private markets, the counterintuitive benefits of AI, and the meritocracy of the investment world.
Key Discussion Points & Insights
1. SurgoCap’s Mission and Investment Philosophy
- SurgoCap’s Goal: Beat the market over a 3-5 year cycle with less risk than the market, with risk defined as loss of capital, not mere volatility.
- Differentiation: Identifying a “very small handful of truly great businesses” by focusing on long duration moats and leveraging a transparent, disciplined process.
- Learning from Experience: Gaonkar credits her approach to “distillation of lessons and mistakes” from 23 years in the business—particularly from her time at Lone Pine Capital.
- Quote:
“The way I define a great business is a business with very long duration moats. And duration really is our true differentiation.”
— Mala Gaonkar [01:21]
2. Defining a Great Business & Industry Focus
- Count of Great Companies: There are only a “small handful” worldwide.
- Every Business is a Tech Business: Gaonkar argues technology underpins even traditional sectors like aerospace or medtech.
- Focus Sectors:
- Enterprise data/technology
- Financial services
- Healthcare services
- Industrial technologies
- Old Tech Disrupting in New Ways: Example—Lithium-ion batteries invented in 1976 now reshaping the auto industry; GPUs evolved from gaming to AI backbone.
- Quote:
"Every business is a technology business… understanding the tech stack map of businesses is something we spend a lot of time on, especially in non tech businesses."
— Mala Gaonkar [01:53] - Quote:
“…GPUs to make our video games look a little more fun. And then fast forward to now they're actually driving… the more tectonic plate shifts… which is AI.”
— Mala Gaonkar [02:31]
3. AI: Counterintuitive Benefits
- Medical Imaging: AI has drastically increased accuracy and speed of MRIs and CT scans—up to 70% improvement.
- Impact: Enables earlier detection and intervention for chronic diseases, improving cost-effectiveness and prevention.
- Robotic Surgery: AI and robotics (e.g., Intuitive Surgical) are penetrating the surgical market, reducing errors and aiding training.
- Promise for Healthcare Costs: Gaonkar is hopeful about AI’s potential for broader cost containment.
- Bias Reduction: Data-driven approaches help “debias the very human decision making process.”
- Quote:
"In the imaging space… the accuracy and the speed at which these images can be conducted are now improving at a pace of almost 70% versus what we would have even a few years ago."
— Mala Gaonkar [03:13]
4. Concentration and Thematic Investing
- Intentional Concentration: SurgoCap invests heavily where it has firm conviction, especially in the four verticals where “technology disruption is most relevant.”
- Rationale: Sector focus provides a “clearer path” for incremental returns and allows the fund to “play offense” amid market factor rotations.
- Quote:
“…allows you to play offense when at some point or the other, due to the passive nature of the market structure… could disrupt a portfolio that allows us to play offense during those periods.”
— Mala Gaonkar [05:49]
5. Public vs Private Investments
- Why Private?: The most disruptive innovation often emerges from the “edges”—smaller, private companies with unsung founders.
- Global View: SurgoCap maintains networks beyond the US to spot global innovation in its focus sectors.
- Quote:
“Change always happens at the edges, not at the core… the private company, the unsung founder who's just emerging, that's really where change at the margin will happen.”
— Mala Gaonkar [06:36]
6. The Art & Challenge of Shorting
- Contrasts with Long Investing: Shorting requires a uniquely different mindset; timing is critical, and clear “winner/loser” pairs are rare.
- Market Structure Matters: Modern dynamics (quants, ETFs, factor rotations) add complexity and stress.
- Personal Perspective:
- Tangen: “It's just so, so stressful. I enjoy it because you are wrong for such a long period of time. And when you're right, it's just like in these bursts…” [08:31]
7. Women in Finance and Broader Reflections on Meritocracy
- Role Model Status: Gaonkar holds the record for the largest hedge fund launch by a woman but hopes it’s quickly surpassed.
- Meritocracy in Investing: Identifies finance as “about as meritocratic a business as I can think of.”
- Open Doors: Highlights opportunity for intellectually curious individuals, regardless of background.
- Personal Mission: Aims to be a role model not just for women, but for the entire investment and philanthropic communities.
- Quote:
“I could be a green Martian with two horns in my head, but if I produce investment returns, there'll be a line out the door wanting to get my product.”
— Mala Gaonkar [09:25] - Quote:
“It's a terrific [industry] for people who are intellectually curious of all stripes and shapes and sizes to come in and be of use to the world at large.”
— Mala Gaonkar [09:51]
Memorable Moments & Notable Quotes (with Timestamps)
-
On Building SurgoCap’s Process:
“Our product is really our process, a very transparent process of looking for very specific factors…distillation of my lessons I've learned…the many mistakes and lessons…”
— Mala Gaonkar [00:40] -
On the Rarity of Great Companies:
“A small handful. I don't think there are that many…”
— Mala Gaonkar [01:44] -
On Healthcare AI:
“I think what is happening within medical technologies is not perhaps as well or broadly understood as it should.”
— Mala Gaonkar [03:05] -
On Private Vs. Public Opportunity:
“Change always happens at the edges, not at the core… the private company, the unsung founder who's just emerging, that's really where change at the margin will happen.”
— Mala Gaonkar [06:36] -
On Investment as Meritocracy:
“I could be a green Martian with two horns in my head, but if I produce investment returns, there'll be a line out the door wanting to get my product.”
— Mala Gaonkar [09:25]
Timestamps for Key Segments
- 00:40 — What makes SurgoCap unique
- 01:44 — Defining great companies and sectors of interest
- 03:05 — AI’s unexpected impact in healthcare
- 05:14 — Approach to concentrated investing
- 06:24 — Inclusion of private companies in the strategy
- 07:17 — The stark difference between long and short investing
- 08:31 — Stress and psychology of shorting (Tangen’s observation)
- 09:05 — Breaking records and thoughts on being a woman in finance
- 09:25 — Industry meritocracy and Gaonkar’s broader ambitions
Tone & Style Notes
The exchange is analytical yet approachable, mixing technical insights with personal philosophy and humor (notably in Gaonkar’s “green Martian” remark). Both Tangen and Gaonkar refrain from jargon in favor of clear, illustrative examples—making complex ideas accessible and the episode beneficial even for non-specialists interested in leadership, innovation, and finance.